期刊文献+

HCV感染者外周血T淋巴细胞亚群的变化 被引量:7

Changes of T cell subsets of peripheral blood in patients with HCV infection
暂未订购
导出
摘要 目的研究HCV感染者在病程各阶段外周血T淋巴细胞亚群的变化。方法流式细胞仪检测丙型肝炎患者CD4+、CD8+T淋巴细胞,并将其分为急性期组,慢性期组检测CD4+CD2+5、CD4+CD2-8T淋巴细胞。结果丙型肝炎患者CD4+T细胞降低,CD8+T细胞升高,CD4+/CD8+降低,与对照组差异有统计学意义(P<0.05)。急性期组CD4+CD2+5与正常对照组差异无统计学意义(P>0.05),但CD4+/CD28-T细胞显著高于对照组(P<0.05)、慢性期组CD4++CD25+T细胞显著增高,而CD4+CD2-8T细胞显著低于对照组(P<0.05)。结论丙型肝炎患者CD4+/CD8+明显降低,机体免疫状态紊乱,在各病程阶段CD4+CD25+、CD4+CD28-T细胞比率明显变化,说明此淋巴细胞亚群与丙型肝炎的发病及发展有密切关系。 Objective The changes of peripheral blood T lymphocyte subsets in patients with HCV infection in different courses of disease were studied. Methods Flow cytometry was used to determine the number of CD4^+, CD8^+, CD4^+CD25^+ and CD4^+CD28^-T lymphocyte in patients with HCV infection;and results were analyzed statistically. Results Significantly lower percentage of CD4^+T lymphocyte,and higher of CD8^+ ,with CD4^+/CD8^+ ratio in HCV patients than those in normal control people(P〈 0. 05) ,were demonstrated in the results. It was demonstrate in the result that in the group of patients with acute HCV hepatitis, the percentage of CD4^+ CD25^+ T lymphocyte was near that in control group, but the CD4^+CD28^-T lymphocyte was increased evidently(P 〈0. 05 ), and in the chronic HCV patients group, the percentage of CD4^+CD25^+ T lymphocyte was higher, and the CD4^+ CD28^- lower, significantly(P〈0. 05) than those in control group. Conclusion The results suggest that the ratio of CD4^+/CD8^+T lymphocyte in HCV hepatitis patients is decreased and there is of immune-disorder in these patients. It also suggests that the ratios of CD4^+CD25^+ and CD4^+CD28^-T lymphocyte are of significant changes in acute or chronic HCV hepatitis patients, which means that the changes of these lymphocyte subsest may be of high relationship with the courses of HCV hepatitis.
出处 《四川医学》 CAS 2010年第2期241-242,共2页 Sichuan Medical Journal
关键词 丙型肝炎 CD4^+/CD8^+ CD4^+CD25^+T细胞 CD4^+CD28^-T细胞 hepatitis C CD4^+/CD8^+ CD4^+CD25^+ T cell CD4^+CD28^- T cell
  • 相关文献

参考文献6

  • 1高勇,贺永文,曾令兰,刘薇,易建华.丙型肝炎病毒感染外周血单个核细胞对丙型肝炎的影响[J].同济医科大学学报,2000,29(5):450-452. 被引量:4
  • 2Rosen HR, Miner C, Sasaki AW, et al. Frequencies of HCV specific effector CD4^+ T cells by flow cytometry:correlation with clinical disease stages[ J ]. Hepatology ,2002,35 : 190 - 198.
  • 3Sugimoto K,lkeda F,Stadanlick J,et al. Suppression of HCV specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection[ J ]. Hepatoloy ,2003,38 : 1437 - 1448.
  • 4Cabrera R,Tu Z,Xu Y,et al. An immunomodulatory role for CD4^+CD25^+ regulatory T lymphocytes in hepatitis C virus infection [ J ]. Hepatology ,2004,40 : 1062 - 1071.
  • 5杨江华,张永祥,喻荣彬,苏川,孙南雄.CD_4^+CD_(25)^+调节性T细胞抑制持续性丙型肝炎病毒感染患者CD_4^+T细胞反应[J].中华内科杂志,2006,45(1):29-33. 被引量:11
  • 6Maloy K J, Salaum L, Cahill R, et al. CD4^+ CD25^+ T ( R ) cells suppress innate immune pathology through cytokine-dependent mechanisms[J]. J Exp Meal,2003,197(1) :111 - 119.

二级参考文献16

  • 1丙型肝炎防治指南[J].中华内科杂志,2004,43(7):551-555. 被引量:106
  • 2贺永文,罗端德.周围血白细胞的复制型丙型肝炎病毒RNA的检测及临床意义[J].中华内科杂志,1995,34(7):459-462. 被引量:6
  • 3孙延波.丙型肝炎病毒的感染特点[J].国外医学(微生物学分册),1996,19(4):15-18. 被引量:2
  • 4Frank C,Mohamed MK,Strickland GT,et al.The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.Lancet,2000,355:887-891.
  • 5Asseman C,von Herrath M.About CD4pos CD25pos regulatory cells.Autoimmun Rev,2002,1:190-197.
  • 6Hisaeda H,Maekawa Y,Iwakawa D,et al.Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells.Nat Med,2004,10:29-30.
  • 7Mendez S,Reckling SK,Piccirillo CA,et al.Role for CD4+ CD25+ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity.J Exp Med,2004,200:201-210.
  • 8Aandahl EM,Michaelsson J,Moretto WJ,et al.Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.J Virol,2004,78:2454-2459.
  • 9Baecher-Allan C,Brown JA,Freeman GJ,et al.CD4+ CD25 high regulatory cells in human peripheral blood.J Immunol,2001,167:1245-1253.
  • 10Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells.Nat Immunol,2003,4:330-336.

共引文献13

同被引文献62

  • 1张言超,陈明,李强,颜学兵,潘修成.HCV RNA和抗-HCV联合检测的诊断意义[J].徐州医学院学报,2010,30(8):536-537. 被引量:9
  • 2李文淑,赵景民,周光德,刘树红,郭晓东,杨建法,赵雨来.HCV感染者自身抗体对肝脏损伤的影响[J].中华临床医师杂志(电子版),2011,5(20):5969-5973. 被引量:11
  • 3丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:732
  • 4Post J J, Ratnarajah S, Lioyd A R. Immunological determinants oftheoutcomes from primary hepatitis C infection [J].. Cell Mol Life Sci,2009,66(I) :733 -56.
  • 5European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection [J]. . J Hepatol,2011 ,55(2) :245 -64.
  • 6Hiroishi K, Ito T, Imawari M. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence [J]. . J Gastroenterol Hepatol, 2008 ,23 ( 1 ) : 473 - 82.
  • 7Satake S, Nagaki M, Kimura K. Significant effect of hepatitis C virus specific CTLs on viral clearance in patients with type C chronic hepatitis treated with antiviral agents [J]. . Hepatol Res, 2008 , 38(5) :491 -500.
  • 8Bengsch B,Seigel B,Ruhl M,et al. Coexpression of PD-I, 2B4, CD160 and KLRGI on exhausted HCY-specific CD8 + T cell is linked to antigen recognitionand T cell differntiation [J].. Jplos Pathog,2010, 6(6) :el000947.
  • 9Mccaughan G W, Bowen D G. Pathogenesis of cholestatic hepatitis C [J]. J Hepatol,2011 ,54(2) :392 -4.
  • 10Accapezzato D, Francavilla, Paroli M, et al. Hepatic expansion of a virus-specific regulatory CD8 ( +) T cell population in chronic hepatitis C virusinfection [J]. J Clin Invest,2004,I13(7) :963- 72.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部